2m 2m 2m 2m 2m 2m 2m
OVID THERAPTCS (OVID)
NASDAQ
$2.36+$0.04 (+1.72%)
Price as of Jun 23, 2026 7:46 PM EDT- $419.9MMarket Cap
- 668.98%1-Year Change
- BiotechnologyIndustry
OVID THERAPTCS (OVID)
$2.36+$0.04 (+1.72%)
OVID | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.32 | ||
Change | +$0.07 (+3.11%) | ||
Open | $2.20 | ||
High | $2.33 | ||
Low | $2.19 | ||
Previous Close | $2.25 | ||
Volume | 2,421,898 | ||
30-Day Average Volume | 2,583,284 | ||
1-Week Change | -1.69% | ||
1-Month Change | -6.07% | ||
1-Year Change | 668.98% | ||
3-Year Change | -37.80% | ||
5-Year Change | -45.15% | ||
Fundamentals | |||
Shares Outstanding | 186.6M | ||
Total Assets | $225.6M | ||
Market Cap | $419.9M | ||
Enterprise Value | $325.9M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$17.0M | ||
Free Cash Flow | -$13.9M | ||
EBIT | -$17.0M | ||
EBITDA | -$17.0M | ||
Net Working Capital | $144.4M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -19 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -30 | ||
Price/Operating Cash Flow | -30 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue